Central Drugs Standard Control Organization (CDSCO): News
27 Sep 2024
KeralaMpox update: Centre's advisory after India reports clade 1b case
The Union Health Ministry has issued a nationwide advisory following the detection of India's first Mpox clade 1b case.
11 Oct 2023
UzbekistanUzbekistan cough syrup deaths: India allows company to reopen factory
The Uttar Pradesh government has allowed Marion Biotech, which manufactured the cough syrup responsible for the deaths of 65 kids in Uzbekistan last year, to restart most production, Reuters reported.
05 Oct 2023
World Health OrganizationToxic levels of chemicals found in Indian-manufactured syrups again: Report
The Central Drugs Standard Control Organization (CDSCO) has claimed that the Gujarat Food and Drug Control Administration (FDCA) found toxic levels of ethylene glycol and diethylene glycol in batches of cough and allergic rhinitis syrups manufactured by Norris Medicines.
28 Jun 2023
UzbekistanIndian company used toxic industrial chemical in syrup: Report
The India-made cough syrups linked to at least 19 deaths in Uzbekistan contained a toxic industrial-grade ingredient rather than the legitimate pharmaceutical version, Reuters reported.
18 Jan 2023
Union Health MinistryCentre refutes reports on side-effects of COVID-19 vaccines
The Union Health Ministry on Tuesday rejected reports claiming that the Central Drugs Standard Control Organization (CDSCO) and Indian Council of Medical Research (ICMR) had admitted to numerous side effects of COVID-19 vaccines.
23 Dec 2022
VaccineCOVID-19: Centre approves Bharat Biotech's nasal vaccine as booster dose
Union Health Minister Mansukh Mandaviya informed on Friday that the Centre has approved Bharat Biotech's nasal vaccine to be used as a heterologous booster.
12 Oct 2022
World Health OrganizationHaryana government halts cough syrup production linked to Gambia deaths
The Haryana government suspended cough syrup production at a Maiden Pharmaceuticals facility on Wednesday, a week after the World Health Organization (WHO) warned that the drug may be related to the deaths of scores of children in the Gambia.
06 Oct 2022
Gambia66 Gambia deaths: Centre probes Indian company's 4 cough syrups
After the death of 66 children in the Gambia, the World Health Organization (WHO) issued an alert against using four fever, cold, and cough syrups manufactured by Maiden Pharmaceuticals Limited — an Indian pharmaceuticals company based in Haryana.
20 Aug 2021
Drugs Controller General of IndiaExpert panel recommends emergency use authorization for Zydus's three-dose vaccine
The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) has recommended granting an emergency use authorization (EUA) to ZyCoV-D, the three-dose COVID-19 vaccine developed by Zydus Cadila, on Friday.
02 Aug 2021
Johnson & JohnsonJ&J withdraws vaccine approval request in India, CDSCO says
Johnson & Johnson has withdrawn its proposal seeking an accelerated approval of its COVID-19 vaccine, Janssen, in India, the country's drug regulator said.
30 Jul 2021
Christian Medical CollegeGovernment expert panel recommends conducting trials on mixing Covishield, COVAXIN
The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) has given its go-ahead for conducting clinical trials involving the mixing and matching of Covishield and COVAXIN vaccine doses.
01 Jul 2021
Drugs Controller General of IndiaExpert panel says no to Covovax's children trials in India
A Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) has denied permission to Pune-based Serum Institute of India (SII) for conducting clinical trials of its second COVID-19 vaccine, Covovax, in children.
12 May 2021
VaccineCOVAXIN phase 2/3 trials for 2-18-year-olds recommended by expert panel
In a bid to extend the country's vaccination drive to include people below 18 years, an expert panel on Tuesday recommended Hyderabad-based Bharat Biotech's COVID-19 vaccine COVAXIN for phase 2/3 clinical trials on children and adolescents aged two to 18 years.
15 Apr 2021
CoronavirusForeign COVID-19 vaccines: Decision on EUA applications within three days
India's drug regulator will make a decision on applications seeking approval for restricted emergency use of foreign-produced vaccines within three working days from the date of submission, the government said on Thursday.
20 Jan 2021
Drugs Controller General of IndiaPanel recommends permission for Phase I Intranasal COVID-19 vaccine trial
An expert panel, Central Drugs Standard Control Organisation, (CDSCO) on Tuesday recommended granting permission for conducting the Phase I clinical trial of an intranasal vaccine against COVID-19 developed by Bharat Biotech, official sources said.
03 Jan 2021
Union Health MinistryCoronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod
A government-appointed panel on Saturday recommended emergency-use authorization (EUA) to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech.
01 Jan 2021
OxfordIndia set to start COVID-19 vaccination; panel approves Oxford vaccine
In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca.
31 Dec 2020
IndiaUK's approval to Oxford-AstraZeneca vaccine paves way for India
The United Kingdom on Wednesday approved the vaccine developed by Oxford University and the British-Swedish pharmaceutical company AstraZeneca, giving the vaccine an endorsement that will likely be considered by Indian drug regulators.
02 Dec 2020
CoronavirusTrial will continue: Centre on SII vaccine's "adverse reaction" claims
With the coronavirus vaccine trials being conducted by Serum Institute of India (SII) being shrouded in controversy after a participant complained of an "adverse reaction," the Centre on Tuesday said there's no need to stop the process.
08 Oct 2020
Russia NewsIndia rejects large scale trial of Russia's COVID-19 vaccine
India's drug regulator has refused to allow a large scale clinical trial of Russia's Sputnik V COVID-19 vaccine.
16 Sep 2020
Russia NewsDr. Reddy's bringing coronavirus vaccine to India by 2020-end
In a major development, Hyderabad-based pharma company Dr. Reddy's Laboratories has partnered with the Russian Direct Investment Fund (RDIF) to source their Sputnik V COVID-19 vaccine for India.
12 Aug 2020
IndiaCoronavirus: How soon could Russian vaccine be available in India?
On Tuesday, Russia announced what it claims is the first COVID-19 vaccine, developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Moscow.
02 Jun 2020
United States of AmericaRemdesivir reportedly approved for COVID-19 treatment in India
Remdesivir has been approved by India's top drug regulator for "restricted emergency use" on COVID-19-infected adults and children.
24 Mar 2020
India#GoodNews: Pune's Mylab approved to make COVID-19 test kits
In a major development, Pune-based molecular diagnostics company Mylab Discovery Solutions has been given the go-ahead to develop testing kits for the novel coronavirus disease (COVID-19).
06 Oct 2018
Supreme Court Of IndiaSC seeks Center's response on faulty hip implants by J&J
The Supreme Court yesterday sought the Center's response on a plea alleging that "faulty" and "deadly" hip implants, made by US-based pharma major Johnson & Johnson (J&J), have been fitted into the bodies of 14,525 Indian patients, termed as "medical negligence" by an expert committee.
07 Sep 2018
IndiaHealth Ministry to rename drug regulator CDSCO; invites suggestions
The Union Health Ministry has invited suggestions for renaming the country's drug regulator CDSCO in line with its expanded roles.
03 Jun 2018
IndiaGovernment plans to make companies responsible for drug regulation violations
To ensure the quality of drugs, Health Ministry is planning to make companies, which market and promote medicines, responsible for any violation of drug regulations like manufacturers.
08 Apr 2018
Ministry of Health and Family WelfareHealth Ministry bans sale of 14 steroid-creams sans doctor's prescription
Health Ministry has banned over-the-counter (OTC) sale of 14 steroid-based creams and ointments by bringing them under the Schedule H of the Drugs and Cosmetics Rules, 1945.
19 Sep 2017
Climate ChangeBengaluru Lake Frothing: Centre seeks CPCB's response over phosphorus pollution
Bengaluru's Bellandur Lake frothing has turned the Centre's attention to high phosphorus content in laundry detergents, bars, and industrial cleaners.
